New approaches to the treatment of childhood leukaemia are being developed all the time, and with this project, Owen is focusing on molecular biology. He’s developing models that can predict how certain types of the disease respond to a new set of drugs, and in the future this will improve the treatment options for all children with leukaemia.
Our funding is helping the research team use molecular biology to develop ways of seeing how leukaemia responds to new drugs, an approach that will ultimately lead to improved treatments.
This research project on childhood leukaemia has been successfully completed. Your donations allow us to fund ground-breaking research that can improve treatments given to children with cancer. Thank you. Your help allows us to continue to find ways to drive up the chances of survival for children with cancer and reduce the toxic side effects that can affect the rest of their lives.
Pre-clinical drug validation in acute lymphoid and myeloid leukaemia
Dr Owen Williams
Institute of Child Health, University College London
London WC1N 1EH
1 December 2014